Long Term Physical Activity for Hemodialysis Patients

August 4, 2016 updated by: AURA Sante

Effects of One Year Perdialytic Physical Activity on Aerobic Capacities and Quality of Life in Hemodialysis Patients

Patients on chronic hemodialysis present severe physical dysfunctioning associated with a significant reduction of their muscle mass. These two parameters are associated with increased morbidity and mortality along with deconditioning and poor quality of life. There are several studies- usually short term, single center uncontrolled and underpowered- that have shown a significant improvement of the physical, metabolic and dialytic parameters.

There are only few studies that have measured the impact of a long term intradialytic exercise intervention on a supervised manner. This is a multi-center controlled study examining the effects of intradialytic cycling on parameters of physical functioning, body composition, cardiovascular and nutritional status, immunological status and quality of life in a group of clinically stable hemodialysis patients

Study Overview

Detailed Description

General Context Chronic Kidney Patients (CKD) live a sedentary life. Sedentarity and Sarcopenia worsen during the evolution of CKD with numerous cardiovascular diseases, infectious and other comorbidities. Inactivity may activate and amplify the inflammatory process, hypercoagulability, malnutrition, invoking a vicious circle of further inactivity and deconditioning.

These populations have a very low physical activity profile due to important tiredness, perturbed general condition and bad adaptation in effort. The patients with cardiovascular problems have additional limitations due to breathlessness associated with congestive cardiac failure and intermittent claudication due to peripheral arteriopathy. At the dialysis stages the tiredness is accentuated after the hemodialysis sessions. The days off dialysis are rarely used for practicing a physical activity.

The deconditioning along with the reduction of the physical activity are leading to a de-socializing progressing in the course of the chronic renal failure. In that way the patient feels more and more isolated with a serious eventual impact on the nutrition status and his quality of life.

Regular physical activity in this population of patients is exerting beneficial effects on insulin resistance, inflammation, dialysis efficiency, nutrition and arterial pressure. It may also reduce the intradialytic hypotensive episodes and improve quality of life, without side effects.

The objective of this study is to investigate an improvement of the physical functioning associated with a reprogramming of the autonomous nervous system, a reduction of the pro-inflammatory factors with a reduction of the insulin resistance (reduction of the metabolic syndrome), along with improvements on the immune system functioning for hemodialysis patients participating on a one year intradialytic physical activity program.

Principal objective :

The principal aim of the present study is to show the efficacy of intradialytic physical activity on functional capacity with the sit-to-stand test in 60 seconds (STS60) and the time to perform 5 complete sit-to-stand movements (STS5) along with a 6 minutes' walk test (6MWT).

Secondary objectives :

The secondary objectives are the amelioration of parameters associated with cardiovascular, sympathetic or autonomous nervous system, immune, nutritional, metabolic and inflammatory outcomes among with quality of life.

This is a multicenter, controlled randomized trial

Study description:

Inclusion of patients willing to participate in the study, and consequently their randomization in 2 groups.

The intervention group will benefit from a supervised physical activity during the dialysis session and the other group will carry on with his usual physical activities and have the same tests before and after the trial without undergoing a supervised intradialytic physical activity program

Primary judgment criteria :

The principal criteria will be the effect of an aerobic training program with a warming up phase, followed by 30 minutes of intradialytic cycling on 55% of the VO2max, 3 times a week.

The primary judgement criteria will be the improvement of the Sit-to-stand test in 60 seconds (STS60) and the time to complete 5 sit-to stand movements (STS5) as well as the 6 minutes' walk test (6MWT) from T0 (before the training program) to T12 (12 months after the start of the training period)

Secondary criteria:

  • Quality of life parameters evaluated from the questionaries SF36 (The Short Form (36) Health Survey), Borg scale, EVA.
  • Physical activity levels: IPAQ (international physical activity questionary).
  • Body composition (Fat mass, lean mass, bone mineral density, estimation of the muscular mass) with DEXA (dual-energy x-ray absorptiometry).
  • Cardiovascular parameters : Cardiac echography, doppler of the carotid arteries and the lower extremity arteries, 24h cardiac rhythm exploration
  • Immune parameters: leucocyte subpopulation functioning
  • Nutritional and metabolic parameters: weight, BMI, albumin, pre-albumin, pre- and post-dialytic serum urea and creatinine levels, nPCR (normalised Protein catabolic Rate).
  • Inflammatory parameters :(Interleucin) IL1 bêta, IL6, IL8, IL-10, TNF alpha (Tumor necrosis factor alpha), CRP (C reactive protein)
  • Dialysis parameters : Kt/v, anemia control : Hemoglobin (Hb), MCV (mean corpuscular volume), ferritin, erythropoetin dosage (EPO).
  • Number, etiology and duration of hospitalisations
  • Survival in 1 year

Number of participants : 100, ie 50 per group

Layout of the study :

Inclusion of the patient, evaluations at the start of the study protocol, at 6 months and at the end -12 months (M0, M6, M12).

Benefits and risks of this study :

Improvement of functional aerobic capacity, inflammatory status and quality of life. Improvements on the state of pain, autonomy, augmentation of the lean mass with conservation of the muscular mass for the lower extremities and reduction of the total fat mass are expected as well as improvement of the nutritional status, dialysis parameters, anemia control.

The risks are of cardiovascular origin: a possible decompensation of coronary artery disease, peripheral artery disease, taking into consideration that all patients benefit from echo doppler arterial control before the start of the study.

Regular Perdialytic Activity during Dialysis is practiced in AURA Auvergne (Association pour l'Utilisation du Rein Artificiel Santé) since 2 years; there has been no secondary vascular problem associated with the supervised physical activity. Nevertheless, rare tendon problems or articular and muscular pains could be possible on the course of the study

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 90 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Consenting active hemodialysis patients since at least 6 months aged between 20 and 90 y.o.

Exclusion Criteria:

  • Unstable angina,
  • severe left ventricular dysfunction,
  • Ejection fraction < 30%,
  • severe peripheral arterial disease,
  • lower extremity amputation,
  • impossibility of physical effort: pain, uncontrolled bone/muscular disease,
  • participation on another study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Exercisers
Intradialytic exercise on stationary bicycles
Patients are exercising for 30-60 min during dialysis on an Rated Perceived Exertion (RPE) Scale between 12 and 14
PLACEBO_COMPARATOR: Non Exercisers
No intradialytic exercise
Patients are having their usual physical activity

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improvement of the distance covered after walking for 6 minutes (6 minutes walk test)
Time Frame: 12 months
The principal aim of the present study is to show the efficacy of intradialytic physical activity on the improvement of the physical capacity of the patients assessed with the 6 minutes walk test ((6MWT)
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life parameters 1
Time Frame: 12 months
Quality of life parameters evaluated from the questionnaire SF36 QD
12 months
Quality of life parameters 2
Time Frame: 12 months
Quality of life parameters evaluated from the questionnaire Borg scale
12 months
Quality of life parameters 3
Time Frame: 12 months
Quality of life parameters evaluated from the EVA scale
12 months
Physical activity levels
Time Frame: 12 months
Physical activity levels from the questionnary IPAQ (international physical activity questionnairy)
12 months
Body composition
Time Frame: 12 months
Body composition (Fat mass, lean mass, bone mineral density, estimation of the muscular mass) with DEXA ccanning and bioimpendance
12 months
Cardiovascular parameters
Time Frame: 12 months
Cardiovascular parameters : Cardiac echography, echodoppler of the carotid arteries and the lower extremity arteries, 24h cardiac rythm exploration
12 months
Immune parametres
Time Frame: 12 months
Immune parametres: leucocyte subpopulation fonctioning
12 months
Nutritional and metabolic parameters 1
Time Frame: 12 months
BMI
12 months
Nutritional and metabolic parameters 2
Time Frame: 12 months
serum albumin levels
12 months
Nutritional and metabolic parameters 3
Time Frame: 12 months
serum prealbumin levels
12 months
Nutritional and metabolic parameters 4
Time Frame: 12 months
pre and post dialytic serum urea levels
12 months
Nutritional and metabolic parameters 5
Time Frame: 12 months
pre and post dialytic serum creatinine levels
12 months
Nutritional and metabolic parameters 6
Time Frame: 12 months
nPCR (normalised Protein Catabolic Rate)
12 months
inflammatory parameters 1
Time Frame: 12 months
IL1 bêta
12 months
inflammatory parameters 2
Time Frame: 12 months
IL6
12 months
inflammatory parameters 3
Time Frame: 12 months
IL8
12 months
inflammatory parameters 4
Time Frame: 12 months
IL-10
12 months
inflammatory parameters 5
Time Frame: 12 months
TNF alpha
12 months
inflammatory parameters 6
Time Frame: 12 months
CRP
12 months
Dialysis parameters
Time Frame: 12 months
Kt/V
12 months
Anemia control 1
Time Frame: 12 months
Hemoglobin (Hb)
12 months
Anemia control 2
Time Frame: 12 months
MCV (mean corpuscular volume)
12 months
Anemia control 3
Time Frame: 12 months
Ferritine
12 months
Anemia control 4
Time Frame: 12 months
Erythropoetine dosage (EPO).
12 months
Number of hospitalisations
Time Frame: 12 months
Number of hospitalisations
12 months
Duration of hospitalisations
Time Frame: 12 months
Duration of hospitalisations
12 months
Survival
Time Frame: 12 months
Survival in one year
12 months
Improvement of Sit to Stand test in 60 seconds (STS60)
Time Frame: 12 months
The physical capacity of the patients assessed with the number of cycles performed during a sit-to-stand test in 60 seconds (STS60).
12 months
Improvement of the time needed to perform 5 Sit to Stand cycles (STS5)
Time Frame: 12 months
Time needed to perform 5 Sit to Stand cycles (STS5)
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2016

Primary Completion (ANTICIPATED)

September 1, 2018

Study Completion (ANTICIPATED)

May 1, 2019

Study Registration Dates

First Submitted

July 14, 2016

First Submitted That Met QC Criteria

August 4, 2016

First Posted (ESTIMATE)

August 9, 2016

Study Record Updates

Last Update Posted (ESTIMATE)

August 9, 2016

Last Update Submitted That Met QC Criteria

August 4, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • AURAS
  • ID-RCB 2015-A0031-48 (OTHER: CPP Clermont Ferrand)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on End Stage Renal Disease on Hemodialysis

Clinical Trials on Intradialytic exercise on stationary bicycles

Subscribe